cancer

Researchers discover how one type of T cell creates daughter cells that are functionally distinct, but genetically identical

by

Scientists at St. Jude Children’s Research Hospital have solved the mystery of immunology. A CD8+ T cell can contain two functionally distinct daughter cells after dividing, although the cells are genetically identical. The researchers explained how they uncovered one method the immune system uses to provide immediate and long-term protection. Today’s search appears in molecular … Read more

The future outlook for technology-based personalized care in healthcare and life sciences

by

In the next five years, healthcare and life sciences organizations will experience unique disruptive forces presented by a digital-first world that will shape many aspects of the industrial landscape from value-based care to digital prescription treatments. A report by IDC Research, a leading global market research firm, provides some predictions about how organizations can navigate … Read more

Vyriad, Inc. $29.5 million in Series B funding led by a well-known genetics entrepreneur

by

Newswise – Rochester, Minnesota.And May 17 2022 /PRNewswire/ — Vyriad, Inc. , a clinical-stage biotechnology company that develops oncolytic virus therapies to treat a wide range of cancers, today announced $29.5 million in new funding led by Harry Stein of Stine Seed Farms, Inc. With the participation of existing investors. Stine Seed Farms joins Mayo … Read more

Most men with low-risk prostate tumors forgo treatment now

by

number of men with Prostate cancer Those choosing active surveillance (AS) doubled nationwide between 2014 and 2021, according to experts who say the massive increase reflects a growing understanding among researchers and patients alike that low-grade prostate tumors can be safely monitored for years without the need for treatment. Dr. Matthew Cooperberg Nearly 60% of … Read more